Hink, U; Münzel, T
COX-2, another important player in the nitric oxide-endothelin cross-talk: good news for COX-2 inhibitors?Circ Res. Bd. 98. H. 11. 2006 S. 1344-1346
Kleschyov, AL; Strand, S; Schmitt, S et al.
Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2Free Radical Bio Med. Bd. 40. H. 8. 2006 S. 1340-1348
Förstermann, U; Münzel, T
Endothelial nitric oxide synthase in vascular disease: from marvel to menace.Circulation. Bd. 113. H. 13. 2006 S. 1708-14
Wenzel, J; Lubos, E; Schnabel, R et al.
Evaluation of eNOS polymorphisms and the risk of future cardiovascular events in the AtheroGene studyEur Heart J. Bd. 27. 2006 S. 129 Suppl 1
Schnabel, R; Messow, CM; Lubos, E et al.
FLT-1 as an early diagnostic marker in acute coronary syndromes (Group Author(s): AtheroGene)Eur Heart J. Bd. 27. 2006 S. 152 Suppl 1
Schlitt, A; Blankenberg, S; Yan, D et al.
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.Nutr Metab Cardiovasc Dis. Bd. 3. 2006 S. 5
Morange, PE; Bickel, C; Nicaud, V et al.
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease.Arterioscler Thromb Vasc Biol. Bd. 26. 2006 S. 2793-2799
Blankenberg, S; Godefroy, T; Poirier, O et al.
Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.Circ Res. Bd. 99. 2006 S. 102-108
Sinning, JM; Bickel, C; Messow, CM et al.
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.Eur Heart J. Bd. 27. H. 24. 2006 S. 2962-8
Baldus, S; Mullerleile, K; Chumley, P et al.
Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.Free Radic Biol Med. Bd. 41. H. 8. 2006 S. 1282-1288